ArticleNeuro-oncology advances

Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.

Tomoyoshi Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.